A recent study aimed to investigate the clinical and psychosocial risk factors that are associated with hospital readmissions for acute exacerbations of chronic obstructive pulmonary disease among patients.
One of the leading causes of hospitalization in the United States is due to acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Due to its prevalence, many healthcare organizations and government agencies aim to reduce its frequency due to the heavy financial and health burden. A recent study aimed to investigate the clinical and psychosocial risk factors that are associated with readmissions for COPD exacerbations among patients.
The study assessed the clinical and psychosocial risk factors associated with readmissions for COPD exacerbations, specifically among patients of an academic community hospital which implemented a comprehensive care management program (CCMP). The study involved an analysis of patients admitted to Danbury Hospital, where a COPD readmission reduction initiative was implemented.
“The Agency for Healthcare Research and Quality estimates that 1 out of every 5 patients over the age of 40 who have been hospitalized in the past decade carries a diagnosis of chronic obstructive pulmonary disease (COPD),” noted the study. “Given its prevalence in hospitalized patients, COPD and its acute exacerbation pose a heavy financial burden in health care.”
Exacerbation of COPD was defined by the study as increased cough, increased sputum, change in sputum color, or increased dyspnea in a patient with COPD. Data was collected on patients with a diagnosis of AECOPD, including an assessment of their clinical comorbidities, such as pneumonia, presence of musculoskeletal disorders, cognitive disorders, anxiety disorders, substance abuse, and smoking status. Psychosocial risk factors were also evaluated, including anxiety, home safety, and access to transportation.
Throughout the study period, between September 2014 and September 2015, there were a total of 366 admissions for COPD exacerbations among 291 patients. Of these patients, 272 met the criteria to be included in the study. The analysis revealed that 20 patients were readmitted within 30 days of their index hospitalization, and 252 patients were not readmitted. Of those readmitted, the mean age was 74.3 years, while the mean age was 73.1 years among those who has a single admission.
Patients who were readmitted were significantly more likely to have pneumonia at readmission compared with those who were not readmitted (30% versus 13.1%, P < 0.05). No statistically significant difference was seen between the 2 groups with respect to any other comorbidities. Patients who were readmitted within 30 days were significantly more likely than those who were not readmitted to have safety issues at home (80% versus 39.3%, P <0.001), anxiety (60% versus 29.8%, P <0.01) and lack of transportation (35% versus 15.5%, P <0.05).
The researchers found no statistically significant differences between those who were readmitted and those who were not in respect to age, smoking status, gender, or BMI.
Following the 1-year post implementation of the CCMP, the annual readmission rate decreased from 21.5% to 13.6%.
“From a community hospital that has successfully reduced readmissions for AECOPD after implementation of our CCMP, we speculate that a CCMP can reduce readmission rates with careful execution of a program that includes optimization of in-hospital care, better coordination of pre- and post-discharge care, attention to social variables, a system to better identify patient problems after discharge, and an office setup that can accommodate same day sick visits,” concluded the study.
Reference
Euceda G, Kong WT, Kapoor A, Dilauro P, Ogunnaike R, Chronakos J. The effects of a comprehensive care management program on readmission rates after acute exacerbation of COPD at a community-based academic hospital. In press. Chronic Obstr Pulm Dis. 2018; 5(3): doi: 10.15326/jcopdf.5.3.2017.0177
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
FDA Approves Dupilumab as First Biologic Treatment for COPD
September 27th 2024The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype to significantly help reduce exacerbations and improve lung function.
Read More
Social Frailty Indirectly Affects Anxiety, Depression in Patients With AECOPD Through Social Support
September 11th 2024Social frailty in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) does not directly impact anxiety or depression but influences these conditions indirectly through social support.
Read More